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KNOWLEDGE ABOUT NEXPLANON AMONG ADOLESCENTS IN AN URBAN 
PEDIATRIC EMERGENCY ROOM  
KAVITA H. JARIWALA 
ABSTRACT 
INTRODUCTION 
 Adolescent (14-17 year-olds) and young adult (18-20 year-olds) women account 
for a disproportionate 20% of the total number of unintended pregnancies that occur 
among women of all reproductive ages (14-55 year-olds) each year in the US. Nearly half 
(41%) of all unintended pregnancies result from the 18% of women who report 
inconsistent, incorrect, or no use of their contraceptive method. Evidence shows that a 
large proportion of these young women, especially those who are sexually active, come 
to the emergency department for their core sexual and reproductive health care needs. By 
obtaining a better understanding of the sexual and reproductive health needs and 
preferences of an urban population that is disproportionately low income and ethnically 
and racially diverse, our hope is to maximize adolescent and young adult accessibility to 
contraceptive services most feasible in the PED environment such as Nexplanon®, in 
addition to the provision of comprehensive contraceptive counseling and education.  
OBJECTIVES 
 The first objective of this subgroup analysis is to determine the percentage of 
adolescent and young adult females presenting to an urban PED who are familiar with 
Nexplanon® and to describe the demographic, sexual health, and contraceptive use 
characteristics of these young women. The second main objective of our study is to 
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evaluate the sources of Nexplanon®-related information reported by respondents familiar 
with Nexplanon®. In addition to the main objectives, we also determine participant 
willingness to initiate or switch to Nexplanon® and receptivity to learning about 
contraceptive methods during a related or nonrelated visit to the PED.  
METHODS 
 This is a cross-sectional descriptive study using a paper-based anonymous 
questionnaire distributed to female patients, ages 16-21 years, presenting to a Boston 
urban pediatric emergency department (PED). This is a sub-group analysis of a larger 
study aimed at describing the contraceptive use history of young women who present to 
the PED. To identify if any statistically significant categorical variables existed between 
the two assigned groups, univariate analysis was performed using Chi-squared tests. 
Odds ratios with 95% confidence intervals (CIs) were obtained for the relationship 
between participants who have heard of Nexplanon® and the three statistically 
significant variables: history of STDs, gravidity, and prior sexual intercourse with a male. 
Mean and Standard Deviation were used to describe the one continuous variable, age, 
followed by univariate analysis using independent t-test. Statistical significance was 
indicated using p-values for the categorical variables and odds ratio with 95% CI for the 
continuous variable—age. 
RESULTS 
 Of the 366 adolescent and young adult females included in our subgroup analysis, 
230 (62.8%) indicated they were familiar with Nexplanon®. We found that female 
participants familiar with Nexplanon® were 1.3 times more likely to have had a prior 
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STI, twice as likely to have had one or more previous pregnancies, and 3.5 times more 
likely to have previously engaged in sexual intercourse with a male compared to those 
female participants unfamiliar with Nexplanon®. We also found that most (42.2%) 
female participants familiar with Nexplanon® obtained their contraceptive information 
from their family and friends only, while about a third obtained their contraceptive 
information from medical professionals only. Among our total population of respondents, 
6% (22/366) of our sub-group participants identified the contraceptive implant as their 
current method of contraception.  Lastly, approximately 21% of female participants 
familiar with Nexplanon® indicated current use of a long-acting reversible contraceptive 
method at the time of the survey.  
CONCLUSION 
 Overall, our study findings are supportive of and consistent with the provision and 
education of Nexplanon® in the PED. This would be a crucial opportunity to provide 
comprehensive contraceptive counseling and convenient access to the most effective 
method of contraception among a population that disproportionately affected by 
unintended pregnancy. This can be made possible by enabling PED health care providers 
with the proper access to and training in Nexplanon®. By adapting these patient-centered 
practices and techniques, the PED setting can contribute to the notable reduction in teen 
pregnancy seen in a variety of similar clinic-based interventions. The PED atmosphere 
has enormous potential to serve young women as an additional venue for contraception 
education and access.
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INTRODUCTION  
Although the national rate of unintended pregnancy among women of all 
reproductive ages (14-55 years) decreased by an encouraging 18% between 2008 and 
2011 (Finer & Zolna, 2016), unintended pregnancies still account for just over half (51%) 
of all pregnancies each year in the United States (US) (Birgisson, Zhao, Secura, Madden, 
& Peipert, 2015). Adolescent (14-17 year-olds) and young adult (18-20 year-olds) 
women account for a disproportionate 20% of the total number of unintended pregnancies 
that occur among women of all reproductive ages (14-55 year-olds) each year in the US 
(Craig, Dehlendorf, Borrero, Harper, & Rocca, 2014). Young women among racial and 
ethnic minorities are especially disproportionately affected by unintended pregnancies 
with Hispanic and African American adolescent and young adult women being twice as 
likely to become pregnant and give birth compared to white adolescent and young adult 
women (Martinez, Copen, & Abma, 2011). Overall, this translates into approximately 
553,000 teen pregnancies occurring each year in the US, of which an alarming 75% are 
reported to be unintended or unplanned (“American Teens’ Sexual and Reproductive 
Health,” 2016).  
Despite an over 50% decline in the teen pregnancy rate in 2011 and a 57% decline 
in the teen birth rate in 2014 compared to the peak rates that occurred in the early 1990’s, 
disparities in unintended pregnancy by race, ethnicity, and age are still very much a 
public health concern (Craig et al., 2014). In 2010, 60% of all teen pregnancies resulted 
in births, 26% resulted in abortions, and 15% resulted in miscarriages (Sedgh, Finer, 
Bankole, Eilers, & Singh, 2015).Unintended pregnancies lead to significant negative 
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health and socioeconomic outcomes among these disproportionately affected populations 
(Parks & Peipert, 2016). Because unintended pregnancies can be associated with a delay 
in prenatal care, teen births are threatening to young mothers and their infants (Finer & 
Zolna, 2016). Some adverse health outcomes of teen births include: higher rates of 
depression among teen mothers, premature and low-birth weight infants, long-term 
behavioral and physical deficits among children, and lower rates of breastfeeding (Parks 
& Peipert, 2016). Some negative socioeconomic effects of teen births include: higher 
rates of intimate partner victimization, attainment of only lower level educational 
advancement, limited career progression, and poverty (Parks & Peipert, 2016). In 
addition to threatening young women and their families with negative health and 
socioeconomic outcomes, teen births also generate substantial national public health costs 
(Sonfield, Kost, Gold, & Finer, 2011). In 2010, the national cost of unintended 
pregnancies amounted to $ 9.4 billion (Raidoo & Kaneshiro, 2015).  
Nearly half (41%) of all unintended pregnancies result from the 18% of women 
who report inconsistent use of their contraceptive method (Frost & Darroch, 2008). In 
addition to inconsistent use of contraceptive methods, incorrect and no use of 
contraceptive methods also contribute to the high incidence of unintended pregnancies in 
the US (Daniels, Daugherty, & Jones, 2014). In the past two decades, there have been 
numerous studies and local initiatives in the medical and public health communities to 
better understand and address the extensive impact that varying degrees of contraceptive 
use has on the disproportionately high unintended pregnancy rate in the US (Foster et al., 
2015). 
	 3	
 
As a result, the recent notable progress made in the decline of unintended pregnancies 
among adolescent and young adult females can be largely attributed to the increased use 
of more effective reversible contraceptive methods and concurrent decreased use of less 
effective reversible contraceptive methods (Abraham, Zhao, & Peipert, 2015).  
In order to continue the advancements made in the reduction of the national 
unintended pregnancy rate, it is important to be able to reach the populations that are 
considered among the highest risk for unintended pregnancy—adolescent and young 
adult females among racial and ethnic minorities (Chernick, Kharbanda, Santelli, & 
Dayan, 2012). Evidence shows that a large proportion of these young women, especially 
those who are sexually active, come to the emergency department (ED) for their core 
sexual and reproductive health (SRH) care needs. In a study based in suburban and urban 
pediatric emergency departments (PED), it was found that 51% of sexually experienced 
young women were more likely to have more than one ED visit within the past year 
(Miller, Pickett, Leisner, Sherman, & Humiston, 2013). As such, the PED should be 
considered a crucial setting in which contraceptive counseling and provisional practices 
are implemented and disseminated (Fine & Mollen, 2010).  
Sexual & Reproductive Health Characteristics and Behavioral Patterns of US 
Adolescents & Young Adults 
 The adolescent and young adult years are a transitional time period in which vital 
sexual and reproductive developmental changes occur (Society for Adolescent Health and 
Medicine et al., 2014). In addition to undergoing emotional and physical changes, 
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adolescents and young adults are also susceptible to external environmental social and 
peer pressures that can ultimately lead to uncharacteristic high-risk sexual behaviors 
(Miller et al., 2013). High-risk sexual behaviors have been found to be prevalent among 
adolescent and young adult females who rely on the ED for their health care needs (Fine 
& Mollen, 2010). A recent study that took place in the PED defines high-risk sexual 
behaviors to include: sexual debut before age 15, no condom use at last sexual 
intercourse, substance use before last sexual encounter, having greater than three sexual 
partners in the past three months and having greater than 4 lifetime sexual partners 
(Miller et al., 2013). 
According to data obtained from the 2011-2013 National Survey of Family 
Growth (NSFG), 4.3 million (44%) never married 15-19 year-old females and 4.8 million 
never married (47%) 15-19 year-old males have experienced sexual intercourse in the 
US. Approximately half of all never married 15-19 year olds have initiated sexual 
intercourse by the age of 17 (Finer & Philbin, 2013). Some characteristics associated with 
early initiation of sexual intercourse and the progression of sexual activity among 
adolescents and young adults that remain fairly similar across developed countries 
(Sedgh et al., 2015) include a greater number of lifetime sexual partners and increased 
odds of contracting an STI (Miller et al., 2013). However, in contrast to these 
characteristics, contraceptive use is a characteristic of early initiation of sexual 
intercourse that differs between the United States and other developed countries (Sedgh 
et al., 2015).  
Contraceptive Use among US Adolescents & Young Adults 
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Of the 4.3 million never married 15-19 year-old female population in the US, 
79% report using a contraceptive method during their first sexual intercourse: 93% 
among 18-19 year-old females and 77% among 15-17 year-olds (Finer & Philbin, 2013). 
The most common contraceptive methods used among young adult and adolescent 
females continue to be the methods considered least or at best, moderately effective 
against pregnancy prevention: condoms (97%), withdrawal (60%), and oral contraceptive 
pills (OCP) (54%) (Daniels et al., 2014). Over the past decade, the use of condoms has 
increased while the use of the withdrawal method has remained mostly unchanged among 
young women in the US (Finer, 2010). The contraceptive methods that young women 
continue to rely on the most have some of the highest typical use effective rates during 
the first year of use: condoms (18%) and OCPs (9%) (Martinez et al., 2011). There is an 
inconsistency between their use of the least effective contraceptive methods and their 
desire to not become pregnant, reported by 95% of young women presenting to a PED 
(Miller et al., 2014). 
This inconsistency might be addressed by the various factors that influence a 
young woman’s contraceptive choice (Hoopes, Gilmore, Cady, Akers, & Ahrens, 2015). 
An important term that summarizes the contraceptive decision-making process for any 
woman is contraceptive understanding, which includes a combination of knowledge, 
attitudes, and beliefs regarding contraceptive methods (Carter, Bergdall, Henry-Moss, 
Hatfield-Timajchy, & Hock-Long, 2012). These are three components of any woman’s 
contraceptive understanding that have a significant impact on the ultimate decision made, 
whether they are misconceptions or accurate information (Spies, Askelson, Gelman, & 
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Losch, 2010). Several studies on young women’s attitudes and beliefs about various 
contraceptive methods show more misconceptions and a general lower level of accurate 
knowledge and information about LARC methods in particular.  
Long-acting Reversible Contraception 
Currently, there are three long-acting reversible contraceptive methods available 
in the US that include: the levonorgestrel-releasing intrauterine system (LNG-IUS), the 
copper T380A intrauterine device, and finally the single rod etonogestrel subdermal 
implant (Parks & Peipert, 2016). LARC is designed so that once the LARC method of 
choice is inserted; women no longer have to worry about daily, weekly, or even monthly 
maintenance of contraception coverage—making the effectiveness of LARC independent 
from the human error associated with user adherence (Fontenot & Fantasia, 2015). Due to 
the forgettable manner in which LARC is designed, LARC method perfect use 
effectiveness rates are essentially equivalent to those for typical use (Winner et al., 2012). 
In other words, all of the LARC methods are greater than 99% effective (Secura, 
Madden, et al., 2014). The cumulative contraceptive failure rate for combined LARC 
methods over the past 3 years amount to less that 1% and is 20 times lower than the 
cumulative contraceptive failure rate for combined hormonal methods including the 
patch, ring, and OCP (Birgisson et al., 2015). Another benefit associated with LARC is 
convenience. One-time placement of a method provides extended periods of continuous 
pregnancy prevention with greater than 99% efficacy (Parks & Peipert, 2016). The Food 
and Drug Administration (FDA) has approved contraceptive coverage of 3 years for the 
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subdermal implant, 5 years for the LNG-IUS, and 10 years for the copper IUD (Winner et 
al., 2012). 
Increased awareness of these advantages associated with LARC use is crucial in 
improved LARC uptake among the adolescent and young adult populations. This 
important association was most clearly displayed in the Contraceptive CHOICE Project 
(CHOICE) model of contraceptive provision (Frost, Lindberg, & Finer, 2012). 
Evidence from the Contraceptive CHOICE Project 
CHOICE—an observational cohort study of 9256 14-45 year-old women in the 
St. Louis region—aimed to decrease the incidence of unintended pregnancies by 
eliminating financial, educational, and access barriers to all contraceptive methods 
available in the US (Mestad et al., 2011). After receiving tier designed counseling on all 
reversible contraceptive options available in the US, participants were provided with the 
reversible contraceptive method of their choice at no cost for 2-3 years (Birgisson et al., 
2015). All participants were provided with standardized and comprehensive tier 
structured counseling on all contraceptive methods, starting with the most effective 
methods: long-acting reversible contraception (LARC) (Madden, Mullersman, Omvig, 
Secura, & Peipert, 2013). The contraceptive counseling design used in CHOICE served 
as a tool to increase awareness of LARC, in addition to providing comprehensive, 
accurate, and unbiased information on all reversible forms of contraception (Secura, 
Adams, Buckel, Zhao, & Peipert, 2014). 
The CHOICE model of contraceptive method provision had a significant 
influence on the increased uptake of LARC (Birgisson et al., 2015). Among all of the 
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CHOICE participants, 75% chose one of the three LARC methods: 46% LNG-IUS, 12% 
copper IUD, and 17% implant (Birgisson et al., 2015). Of all the women who chose a 
LARC method, 69% were between the ages of 14-25 years (Birgisson et al., 2015), 
indicating a prevalence of LARC uptake among adolescent and young adult women. 
Among the younger CHOICE participants who chose a LARC method, 65.5% of the 14-
17 year-olds chose the implant and 61.4% of the 18-20 year-olds chose the IUD (Mestad 
et al., 2011).  
In addition to the notable shift seen in LARC use among the CHOICE 
participants, evidence from CHOICE also indicates that the continuation rates among 
LARC users at 12 and 24 months were greater (87% and 77%, respectively) than those 
among non-LARC users (57% and 41%, respectively) (OʼNeil-Callahan, Peipert, Zhao, 
Madden, & Secura, 2013). Although slightly less than the continuation rates among all 
CHOICE participants that chose a LARC method, the continuation rates of LARC users 
among 14-19 year-old CHOICE participants were still greater (82% and 67%, 
respectively) than those among non-LARC users (49% and 37%, respectively) at the 12 
and 25 month point (Rosenstock, Peipert, Madden, Zhao, & Secura, 2012). All in all, the 
increased uptake of LARC methods with associated high continuation rates and low 
discontinuation rates (7% within the first 6 months) demonstrated in CHOICE translated 
to a 79% reduction in teen pregnancy (Secura, Allsworth, Madden, Mullersman, & 
Peipert, 2010). 
  The CHOICE model demonstrated that LARC uptake can be optimized and even 
preferred among most women when financial, accessibility, and counseling barriers are 
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removed from providing reproductive health care to women of all ages—especially 
among adolescent and young adult women who are disproportionately effected by 
unintended pregnancies (Secura et al., 2010). This is encouraging since the unique 
multifaceted approach used by CHOICE is adaptable and can be implemented in a variety 
of clinical settings (Birgisson et al., 2015). 
As a result, the American College of Obstetricians and Gynecologists (AGOG), 
the American Academy of Pediatrics (AAP), and the Society for Adolescent Health and 
Medicine (SAHM) recommend LARC as top tier contraception for all women, but 
especially among adolescent and young adult women (Foster et al., 2015). However, 
despite the official recognition of long-acting reversible contraceptive methods as the 
most effective contraceptive methods in pregnancy prevention, LARC methods remain 
underutilized among adolescent and young adult female populations (Denno, Hoopes, & 
Chandra-Mouli, 2015).  
Addressing the Barriers to Increased Uptake of LARC 
 In addition to CHOICE, numerous studies and interventions focused on LARC 
provision have found supporting evidence that barriers to LARC provision and uptake 
exist on multiple levels involving clinical settings, providers, and patients (Murphy, 
Stoffel, Nolan, & Haider, 2016). It is important to address the biggest impediments that 
hinder the increase in LARC uptake among adolescent and young adult females in order 
to better understand the areas in need of improvement or change (Hathaway, Torres, 
Vollett-Krech, & Wohltjen, 2014).  
	 10	
 The nationwide goal to reduce the unintended pregnancy rate through increasing 
LARC uptake starts with improved access to LARC devices at a variety of health care 
facilities throughout the US (Kavanaugh, Jerman, Ethier, & Moskosky, 2013). Without 
having LARC method devices in stock and available, health care providers (HCPs) 
cannot offer the most effective methods of contraception to eligible patients. In turn, this 
contributes to the overall lower LARC awareness among female populations at highest 
risk for unintended pregnancy—adolescent and young adult women (Murphy et al., 
2016). In the case of the subdermal implant, the procurement of Nexplanon® requires the 
health care facility to undergo a company sponsored training program in which its’ 
providers are trained in the insertion and removal of the subdermal implant devices 
(Parks & Peipert, 2016). This requirement helps ensure the provision of Nexplanon® by 
ensuring that HCPs have the knowledge and training necessary to confidently offer these 
contraceptive methods to their patients, especially those known to be at high risk of 
unintended pregnancy. These positive consequences and outcomes were observed in a 
variety of Title-X funded facilities that had these implementations in place (Romero et 
al., 2015). Other clinic-based settings that were randomized to these interventions 
experienced twice as much LARC uptake and a resulting 50% reduction in their 
unintended pregnancy rate (Harper et al., 2015).  
 The barriers associated with health care providers include: lack of confidence and 
training in LARC device placement and method counseling, confusion about LARC 
eligibility among their patients, and practice of outdated clinical guidelines (Murphy et 
al., 2016). In addition to the updated Centers for Disease Control and Prevention (CDC) 
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issued recommendations for providing quality contraceptive services in a variety of 
clinical settings, potential solutions have also been suggested specifically for primary 
care clinicians through the adolescent medicine fellowship program curriculum (Potter, 
Koyama, & Coles, 2015). By implementing these suggestions at the provider level, there 
will be a greater number of HCPs who feel more comfortable providing same-day LARC 
methods to any and all eligible patients without hesitation (Biggs, Arons, Turner, & 
Brindis, 2013).  
 The barriers associated with adolescent and young adult female patients are 
largely related to the decreased awareness and knowledge of LARC methods discussed 
above (Spies et al., 2010). By increasing LARC awareness and knowledge through 
increased LARC placement and counseling by a variety HCPs, more young women will 
not only know to ask about these very methods when seeking contraceptive services, but 
also share accurate contraceptive information with their friends and family (Frost et al., 
2012).  
 Overall, it is important to see the interdependent relationship among clinic, 
provider, and patient level barriers to increased LARC uptake (Murphy et al., 2016). By 
implementing multifaceted integration models in a variety of clinical settings, these 
barriers can be appropriately addressed and even provide solutions for the other barriers 
(Harper et al., 2015). 
Purpose of a Nexplanon®-specific Subgroup Analysis Study 
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 This is a sub-group analysis of a larger study aimed at describing the 
contraceptive use history of young women who present to the PED and their desire to 
initiate contraception in the PED. The purpose of this subgroup analysis is to explore the 
demographic and sexual health characteristics of females who have heard of the 
subdermal implant, Nexplanon®, as well as examine their reported sources of 
Nexplanon®-related information. By obtaining a better understanding of the sexual and 
reproductive health needs and preferences of an urban population that is 
disproportionately low income and ethnically and racially diverse, our hope is to 
maximize adolescent and young adult accessibility to contraceptive services most feasible 
in the PED environment such as Nexplanon®, in addition to the provision of 
comprehensive contraceptive counseling and education.  
Specific Aims & Objectives: 
To determine the percentage of adolescent and young adult females presenting to an 
urban PED who are familiar with Nexplanon® and to describe the demographic, sexual 
health, and contraceptive use characteristics of these young women. 
o Hypothesis: We hypothesize that our population size and characteristics of 
participants familiar with Nexplanon® will be similar to those reported in 
the literature. 
To evaluate the sources of Nexplanon®-related information reported by respondents 
familiar with Nexplanon®. 
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o Hypothesis: We hypothesize that the majority of respondents familiar with 
Nexplanon® report medical professionals as their source of Nexplanon®-
related information. 
To evaluate the current methods of contraception methods used by adolescent and young 
adult females presenting to an urban PED. 
o Hypothesis: We hypothesize that the current methods of contraception 
reported by our population will be similar to those reported in the 
literature. 
To determine the population size, demographic, sexual, and reproductive characteristics 
of adolescent and young adult females presenting to an urban PED who report current use 
of the subdermal implant.  
o Hypothesis: We hypothesize that our population size and characteristics of 
participants currently using Nexplanon® will be similar to those reported 
in the literature. 
To determine willingness to initiate or switch to the subdermal implant if it was offered 
during a related or nonrelated visit among adolescent and young adult females presenting 
to an urban PED 
o Hypothesis: We hypothesize that the proportion of our population that is 
willing to initiate or switch to the subdermal implant if offered in the PED 
will be similar to those reported in current literature.  
To determine receptivity to learning about contraceptive methods during a related or 
nonrelated visit among adolescent and young adult females presenting to an urban PED. 
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o Hypothesis: We hypothesize that the proportion of our population that is 
receptive to learning about contraceptive methods in the PED will be 
similar to those reported in current literature.  
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METHODS  
 
Study Design 
 This is a cross-sectional descriptive study using a paper-based anonymous 
questionnaire distributed to female patients, ages 16-21 years, presenting to a Boston 
urban pediatric emergency department (PED). This is a sub-group analysis of a larger 
study aimed at describing the contraceptive use history of young women who present to 
the PED and their desire to initiate contraception in the PED. The purpose of this 
subgroup analysis was to explore the demographic and sexual health characteristics of 
females who have heard of the subdermal implant, Nexplanon®, as well as the sources 
providing them with information on Nexplanon®. The Boston University Medical 
Campus’s Institutional Review Board (IRB) approved the study with a waiver of 
documentation of informed consent. According to Massachusetts state law, adolescents 
are able to consent for confidential care regarding their reproductive health, including 
pregnancy prevention and contraceptive counseling; therefore, adolescents provided 
consent to participate with a waiver of parental permission.  
Study Population & Setting 
 This single-site research study was conducted in the pediatric emergency 
department of Boston Medical Center (BMC), an urban and academic facility located on 
the Boston University Medical Campus. BMC is the largest safety-net hospital in New 
England and serves a disproportionate number of low-income patients who are ethnically 
and racially diverse. The BMC pediatric emergency department sees approximately 
27,000 children and young adults up to 22 years of age annually.  
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Survey Content & Development 
 The anonymous, 20-question survey included sections on demographic and 
background (6 questions), use of medical care (3 questions), sexual health and 
contraceptive history (5 questions), interest in contraceptive counseling and prescription 
availability in ED (3 questions), and knowledge of Nexplanon®  (2 questions). The 
demographic and background questions were written to inquire about age, ethnicity, race, 
highest level of education completed, a parent's highest level of education completed, and 
highest level of education the subject planned to complete. The use of medical care 
questions were written to determine participants' use of primary care physicians (PCP), 
the time since last PCP visit, and if birth control options are discussed. The ED based 
questions investigates reason for current ED visit, likelihood of starting or changing to 
any type of birth control if available in the ED today, and which birth control methods 
would be chosen in the ED today. The sexual health and contraceptive history questions 
were asked in order to learn about sexual activity, current method of birth control, 
previous method of birth control, and happiness or reasons for unhappiness with current 
method of birth control, history of sexually transmitted infections, and parity/gravidity. 
The Nexplanon® -specific questions were chosen in light of the ultimate goal of the 
larger study, which is to determine the feasibility of providing certain types of 
contraception in a PED. The subdermal implant’s innovative design allows its 
administration to be quick and easy, making it the most reasonable LARC method to 
provide in an emergency room setting. The questionnaire was first piloted on 10 females 
presenting to the PED who provided oral feedback on their understanding of the 
	 17	
questions to help determine if question types and wording needed to be revised for 
clarity. The survey can be found in Appendix A.  
Recruitment & Data Collection 
 Co-Investigators and research assistants recruited patients from August to 
December 2014 with particular focus on periods of high eligible patient volume—1500 to 
2300 hours—determined from the previous year’s patient volume data. Co-investigators 
or research assistants tracked eligible patients on the PED's real time electronic medical 
tracking system.  All English-speaking females aged 16-21 years presenting to the BMC 
Pediatric ED during the hours that research assistants and co-investigators were available 
were approached for possible enrollment in this convenience sample study. Young 
women were excluded if they were under the custody of the Department of Children and 
Families or the Department of Youth Services, critically or significantly ill, and/or 
developmentally delayed. Once approached, eligible participants were greeted with a 
personal introduction, brief scripted description of the study, explanation of consent with 
participation, followed by instructions on completing the survey. Females who consented 
to participate were given a printed informational handout containing background about   
 The primary outcome for this subgroup analysis was to describe the 
characteristics of young women who have heard of the subdermal implant Nexplanon® 
compared to those who have not heard of Nexplanon® using the following variables: 
age, ethnicity, race, parent’s highest level of education, highest level of education 
planned to complete, access to a regular primary care provider, sexual activity, STD 
history, and number of pregnancies.  
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 Young women who had heard of Nexplanon® were asked about their source(s) of 
information about Nexplanon® --medical professionals, family and friends, media, and 
other.   
Data Analysis 
 Two trained research assistants separately entered the collected data into 
Microsoft Excel 2011 using a pre-determined coding system for responses to the survey 
questions. Data was randomly double entered. Data analysis was completed using SPSS 
Statistics 22  (IBM, Armonk, New York, USA). For the purpose of our sub-group 
analysis, participants were categorized into two groups: females who have heard of 
Nexplanon® and females who have not heard of Nexplanon®. Frequencies and 
percentages were used to describe categorical variables: demographic, sexual health, and 
contraceptive use characteristics. In order to identify if any statistically significant 
categorical variables existed between the two assigned groups, univariate analysis was 
performed using Chi-squared tests. Odds ratios with 95% confidence intervals (CIs) were 
obtained for the relationship between participants who have heard of Nexplanon® and 
the three statistically significant variables: history of STDs, gravidity, and prior sexual 
intercourse with a male. Mean and Standard Deviation were used to describe the one 
continuous variable, age, followed by univariate analysis using independent t-test. 
Statistical significance was indicated using p-values for the categorical variables and 
odds ratio with 95% CI for the continuous variable—age. 
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RESULTS 
From August to December of 2014, a total of 383 participants completed surveys 
for the main cross-sectional study. This sub-group analysis focused on the percentage of 
participants who responded to the specific survey question that asked,  
“Have you heard of the implantable birth control device Nexplanon® that goes under the 
skin in the upper arm (Previously known as Implanon), which is the size of a matchstick 
and lasts for 3 years)?” 
 Yes  No (If no, skip to Question 19) 
 
Of the 383 participants for the main cross-sectional study, 95.6% (N=366) 
responded to the survey question of interest for this sub-group analysis. Demographic, 
sexual health, and contraceptive use characteristics were examined for three specialized 
subset populations including: the total population of respondents to the survey question 
inquiring participant familiarity with Nexplanon®, the percentage of respondents who 
replied with a “yes” (n=230), and the percentage of respondents who replied with a “no” 
(n=136).  
Due to this sub-group study’s specific focus on Nexplanon®, descriptive 
characteristics of the percentage of all respondents who listed Nexplanon® as their 
current method of contraception (n=22) were summarized. 
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Table 1: Demographic & Sexual Health Characteristics of 16-21 year-old females presenting to an urban PED  
  
Yes 
HeardNex 
n=230 
No   
HeardNex 
n=136 
Total 
Population 
n=366 
P 
value 
Age: Mean ± Standard Deviation 19.11 ± 1.55 
18.9 ± 
1.65 
19.04 ± 
1.04 0.22 
Ethnicity:      
 Hispanic 59 (25.7) 38 (27.9) 97 (26.9) 0.49 
 Non-Hispanic 171 (74.3) 93 (68.4) 264 (72.1)  
Race:      
 African American 127 (55.2) 64 (47.1) 191 (52.2) 0.18 
 Asian/Caucasian/Other/Mixed 94 (40.9) 64 (47.1) 158 (43.2)  
Parent 
Level of 
Education: 
     
 Less than High School 24 (10.4) 22 (16.2) 46 (12.6)  
 High School Diploma/GED 75 (32.6) 37 (27.2) 112 (30.6)  
 College (No Degree)/2-yr Assoc. Degree 47 (20.4) 19 (14.0) 66 (18.0) 0.19 
 4-yr BA/BS Degree or Grad/Prof School 51 (22.2) 30 (22.1) 81 (22.1)  
Planned 
Level of 
Education: 
     
 High School Diploma/GED                                      2-yr Associate's Degree 44 (19.1) 19 (14.0) 63 (17.2)  
 4-yr BA/BS Degree 95 (41.3) 59 (43.4) 154 (42.1) 0.51 
 Graduate School / Professional School 71 (30.9) 42 (30.9) 113 (30.9)  
Chief 
Complaint:      
 Only Gyn/GU 30 (14.2) 18 (15.3) 48 (14.5)  
 Only GI 55 (25.9) 27 (22.9) 82 (24.8) 0.93 
 Only Other 121 (57.1) 70 (59.3) 191 (57.9)  
 Gyn/GU ± GI and/or ± Other 6 (2.8) 3 (2.5) 9 (2.7)  
PCP:      
 Yes 191 (83.0) 108 (79.4) 299 (81.7) 0.54 
 No 34 (14.8) 23 (16.9) 57 (15.6)  
Last PCP 
Visit:      
 Within the past year 167 (72.6) 88 (64.7) 255 (69.7)  
 Between 1-2 years ago 27 (11.7) 23 (16.9) 50 (13.7) 0.29 
 Over 2 years ago 10 (4.3) 5 (3.7) 15 (4.1)  
* History 
of STI:      
 Yes 76 (33.0) 27 (19.9) 103 (28.1) 0.01 
 No 150 (65.2) 102 (75.0) 252 (68.9)  
*Gravidity:      
 0 149 (64.8) 104 (76.5) 253 (69.1) 0.006 
 ≥1 78 (33.9) 27 (19.9) 105 (28.7)  
*Sexual 
Activity:      
      
 Yes 206 (89.6) 97 (71.3) 303 (82.8) 0.000. 
 No 22 (9.6) 36 (26.5) 58 (15.8)  
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*History of STIs, Gravidity, and Sexual Activity were characteristics that varied between 16 to 21 year old females 
who were familiar with Nexplanon® and those who were not familiar of Nexplanon® 
*Characteristics that were determined to be statistically significant in chi-square univariate analysis (p-value < 0.05) 
Total Population of Respondents (n=366) 
The mean age of all participants who responded to the survey question about 
Nexplanon® familiarity was 19.04 ± 1.04 years. Among the total respondent population, 
approximately three-fourths and half of the females identified with a Non-Hispanic 
ethnicity and the African American race, respectively. Roughly one-third of the 
respondents had a parent with a high school diploma or GED representing their highest 
level of education, but only 17% of the respondents themselves plan the same for their 
future educations. In fact the majority, roughly a combined 80%, of the respondents 
either plan to receive a degree from a 4-year college (42%) or graduate and professional 
schools (39%). 
 The majority of participants (58%) presented to the PED for complaints 
that were unrelated to gynecological (GYN), genitoureteral (GU), and gastrointestinal 
(GI) concerns followed by roughly a quarter participants who presented to the PED for a 
GI-related complaint. The majority also reported seeing their primary care physician 
(82%) fairly regularly with a last visit having occurred within the past year (70%).  
Sexual health characteristics that best describe the total population of respondents 
include: no previous history of STI’s (69%), sexually active (83%), and zero prior 
pregnancies (69%).  
85% (311/366) of all the respondents shared their current method of contraception 
(at time of the study) in addition to their familiarity with Nexplanon®. 36% practiced 
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abstinence, 29% used a hormonal contraceptive method, 16% used a LARC, 4% used 
condoms, and lastly, 16% relied on male withdrawal or no contraceptive method at all 
(Table 2). 
Table 2: Current methods of contraception reported by 16-21 year-old females in an urban PED 
 
Heard of 
Nexplanon® 
n=230  
Not Heard of 
Nexplanon® 
n=136 
Total 
Population 
n=311 
Abstinence 66 (32.4) 45 (42.1) 111 (35.7) 
Barrier Method (Condom) 8 (3.9) 4 (3.7) 13 (4.2) 
Hormonal Methods (OCP & Shot) 62 (30.4) 28 (26.2) 90 (28.9) 
LARC Methods (Implant & IUD) 42 (20.6) 7 (6.5) 49 (15.8) 
Withdrawal and/or No Method 26 (12.7) 23 (21.5) 49 (15.8) 
 
Respondents Familiar with Nexplanon® (n=230) 
 63% (230/366) of all respondents had heard of Nexplanon®. The mean age of 
these of these participants was 19.1 ± 1.55 years. An independent t-test, used for 
univariate analysis of continuous variables, indicated that the mean age of females did not 
significantly differ between respondents who had heard of Nexplanon® and those who 
had not (p-value = 0.22). 
Other characteristics that did not significantly differ with familiarity of 
Nexplanon® included: ethnicity (p-value = 0.49), race (p-value = 0.18), a parent’s 
highest level of education (p-value = 0.19), personal highest level of education planned to 
complete (p-value = 0.51), chief complaint for ED visit (p-value = 0.78), having a 
primary care physician (p-value = 0.54), and when primary care physician was last seen 
(p-value = 0.30).  
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The three characteristics that did significantly vary with familiarity of 
Nexplanon® included: history of STI (p-value = 0.01 < 0.05), gravidity (p-value = 0.006 
< 0.05), has been sexually active (vaginal sex) with a male before (p-value = 0.000 < 
0.05). 
 In order to quantify the degree of association between the statistically significant 
characteristics and familiarity with Nexplanon®, odds ratios with 95% confidence 
intervals were calculated (Table 3). 
Table 3: Odds Ratios for 16-21 year-old females presenting to an urban PED will be familiar with Nexplanon® 
over unfamiliar with Nexplanon®: adjusted analysis 
 
 
Heard of Nexplanon® vs. Not Heard of Nexplanon®     
(95% CI) 
History of STD:  
Yes 1.31 (0.80-2.15) 
No Reference 
Gravidity:  
0 0.50 (0.30-0.82) 
≥1 Reference  
Sexually Active:  
Yes 3.48 (1.94-6.22) 
No Reference 
 
Current Implants Users 
6% (22/366) of our sub-group analysis population identified the contraceptive implant as 
their current method of contraception. The mean age of participants reporting current use 
of the contraceptive implant was 18.8. The majority (91%) of our implant using 
population racially identified as African American and 59% ethnically identified as 
Hispanic. Among our implant using participants, 90.9% reported having a primary care 
physician (PCP) of which 95% reported discussing contraceptive method options with 
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their PCP. A little over half (57.1%) of implant users reported having a history of an STI. 
66.7% of implant users were nulliparous, while 23.8% reported having one previous 
pregnancy.   The majority of implant users indicated that they were happy with their 
current method of contraception.  
Sources of Contraceptive Information 
In Table 4, the source(s) of Nexplanon®-related information was collated based 
on those respondents familiar with Nexplanon® (n=223) to the survey question asking,  
“How did you hear about Nexplanon®?  (Check all that apply.)” 
  Friends, family     
  Media (internet, magazines) 
   Medical professional (School nurse, primary care doctor, etc.) 
   Other  __________________________ 
 
97% of the respondents who indicated familiarity with Nexplanon® also identified their 
source of information on Nexplanon® (Table 4). The majority of respondents (42%) 
reported family and friends as their only sources of information followed by 30% of 
respondents reporting medical professionals as their sole source of information. 
Table 4: Sources of contraceptive information reported by 16-21 year-old females in an urban PED 
Source of Information Heard of Nexplanon® n=223 
Only Family & Friends 94 (42.2) 
Only Medical Professionals 66 (29.6) 
Only Media 9 (4.0) 
Only Other 12 (5.4) 
Family/Friends + Medical Professionals 33 (14.8) 
Family/Friends + Medical Professionals + Media 9 (4.0) 
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Willingness to initiate or switch to the Implant contraceptive method if offered in 
the PED 
“Which birth control method(s) would you be willing to start or change to if it was 
offered to you here in the emergency room today. (Check all that apply.)” 
   Birth control pills, ring, or patch    
   Injectable (Depo- Provera shot)     
   IUD (Intra uterine device: Mirena, Skyla, Copper Paragard)    
   Implantable (Implanon/Nexplanon)       
   I’m happy with my birth control method and wouldn’t change 
   None 
   Other: ___________________________ 
 
Table 5: Participant willingness to initiate of switch to the Implant if offered in the PED 
Willingness to 
Initiate or Switch to 
the Implant if 
Offered in PED  
 
Heard of 
Nexplanon® 
(N=226) 
 
Not Heard of 
Nexplanon® 
(N=129) 
Total 
Population 
(N=355) 
 
Yes 
 
27 (11.9) 
 
7 (5.4) 
 
34 (9.6) 
 
No 
 
199 (88.0) 
 
123 (95.0) 
 
322 (90.7) 
 
Only 9.6% of the participants in our overall sub-group analysis population 
reported that they would initiate or switch to the implant if it was offered to them in the 
PED. However, the proportion of participants who had heard of Nexplanon® who were 
willing to initiate or switch to the implant if it was offered in the PED was double the 
proportion of willing participants who had not heard of Nexplanon®. 
Discussion about Contraceptive Method Options with a Doctor or a Parent 
“Have you ever talked about birth control options with your primary care physician 
(regular doctor) and/or a parent?” 
  Your Doctor:  Yes           A Parent:  Yes 
                         No      No 
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Table 6: Discussion about Contraceptive Method Options between Adolescent and Young Adult Females and 
their Doctor or Parent 
 
Discussion 
of Contraceptive 
Method Options 
 
 
Heard of 
Nexplanon® 
 
 
Not Heard of 
Nexplanon® 
 
 
 
Total Population 
 
 
Doctor: 
Yes 
No 
N=203 
86.7% 
13.3% 
N=122 
66.4% 
33.6% 
N=325 
79.1% 
20.9% 
Parent: 
Yes 
No 
N=191 
60.2% 
39.8% 
N=109 
42.2% 
57.8% 
N=300 
53.7% 
46.3% 
 
79.1% of the participants in our sub-group analysis population reported that they 
discussed birth control method options with a doctor, while only 53.7% of the 
participants in our sub-group analysis population reported that they discussed birth 
control method options with a parent.  
Receptivity to Learning about Birth Control in the PED 
“If you were being seen in the emergency room for a problem, even if that problem was 
not related to your sexual health, would you be open to learning about birth control?” 
   Yes 
   No  
 
Table 7: Receptivity to Learning about Birth Control in the PED 
 
Receptivity to 
Learning about 
Contraception in 
the PED  
 
Heard of 
Nexplanon® 
N=229 
 
Not Heard of 
Nexplanon® 
N=132 
 
Total Population  
 
N=361 
Yes 68.6% 66.0% 67.6% 
No 31.4% 34.1% 32.4% 
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67.6% of the participants in our sub-group analysis population indicated that they 
were receptive to receiving contraceptive education and information during a current 
related or unrelated visit to the ED.  
 
 
 
 
	 28	
DISCUSSION 
 
Participants Familiar with Nexplanon®  
 Our study found that 63% of the participants in our subgroup analysis population 
had heard of Nexplanon®. This is a drastic increase in Nexplanon® awareness among 
young women from previous similar studies in which only 41.1% (Bachorik et al., 2015) 
and 8.0% (Spies et al., 2010) of women reported any familiarity with Nexplanon®. 
Our sub-group analysis identified three sexual and reproductive health 
characteristics strongly associated with the sub-group participants who had heard of 
Nexplanon®.  These characteristics included: history of an STI, at least one previous 
pregnancy, and prior sexual (vaginal) intercourse with a male. Our study found that 
participants with a history of an STI, at least one previous pregnancy, and prior sexual 
(vaginal) intercourse with a male were more likely to have heard of Nexplanon® 
compared to those participants with no history of an STI, no previous pregnancies, and no 
prior sexual intercourse (vaginal) intercourse with a male. These finding are both similar 
and different from the findings of similar previous studies.  
Our finding that participants with a history of an STI were 1.3 times more likely 
to have heard of Nexplanon® than those with no history of an STI was consistent with 
the findings of Mestad et al. in 2011. Mestad et al. found that having a history of an STI 
was significantly associated with selection of the implant over the IUD among 
adolescents aged 14-20 years who chose a LARC method in the CHOICE project.  
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Our finding that participants with at least one previous pregnancy were twice as 
likely to have heard of Nexplanon® than those participants with no previous pregnancies 
was inconsistent with the findings of Mestad et al. in 2011. 
Our finding that participants with prior sexual (vaginal) intercourse with a male 
were 3.5 times more likely to have heard of Nexplanon® than those with no prior sexual 
(vaginal) intercourse with a male was consistent with findings of multiple previous 
studies. In a similar study conducted by Miller et al. in 2016, the proportion (91%) of the 
total population who reported having experience with vaginal sex was similar in size to 
the proportion (82.8%) of participants who reported having prior vaginal sexual 
intercourse in our subgroup analysis study.  
Our subgroup analysis did not find any racial or ethnic disparities in participant 
knowledge of Nexplanon®. This is inconsistent with previous findings that suggested 
Hispanic women had lower awareness of contraceptives than Caucasian and African 
American women (Craig et al., 2014). 
Sources of Contraceptive Information 
The majority (42%) of our participants reported family and friends as their main 
sources of contraceptive information, closely followed by 30% of our participants 
reporting medical professionals as their sole source of information. Our findings are 
somewhat consistent with those of Khurana et al., who found doctors/nurses (26%) to be 
the most frequently reported source for contraceptive information. A combination of 
media sources (26%), including television/radio (14%) and Internet (12%), were also 
reported frequently, closely followed by the combined percentage (25%) of those who 
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reported parent (10%), friend (12%), and sibling/relative (3%) (Khurana & Bleakley, 
2015). 
Since family and friends were the sources most frequently reported by our 
participants, it is concerning that the lowest level of contraceptive knowledge was found 
to be associated with obtaining contraceptive information from parents (Khurana & 
Bleakley, 2015). Because our survey did not assess the level of contraceptive knowledge 
among our participants, we cannot determine if a lower level of contraceptive knowledge 
is associated with our sub-group analysis population, but it is important to point out that 
approximately half (53.7%) discussed contraceptive method options with a parent. The 
association between obtaining contraceptive information from parents and a lower level 
of contraceptive knowledge might be due to parents finding it more difficult to 
differentiate between providing accurate contraceptive information and sharing personal 
moral attitudes about contraceptive methods (Bader, Kelly, Cheng, & Witt, 2014). Since 
this is a plausible complication that can arise with parents providing contraceptive 
information, it is encouraging that many of our participants reported obtaining their 
contraceptive information from medical professionals. In contrast to what was found with 
parents, Khurana et al. found the highest level of contraceptive knowledge to be 
associated with obtaining contraceptive information from doctors/nurses, which was 
predominantly the case among females compared to males. Our data was consistent with 
these findings and showed that a significant proportion of our sub-group analysis 
population (79.1%) discussed contraceptive method options with their doctors.  
Current Contraceptive Method Use 
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The majority (35.7%) of our sub-group analysis population indicated that they 
practiced abstinence, which is consistent with more recent evidence showing that 
teenagers are waiting longer to initiate sexual intercourse (Finer & Philbin, 2013). The 
practice of abstinence was more common among the participants who were not familiar 
with Nexplanon® (42.1%) compared to those who were familiar with Nexplanon® 
(32.4%). This might be indicative of a more sexually active population being familiar 
with Nexplanon® and is consistent with the strong association our sub-group analysis 
found between participants who have previously engaged in vaginal sexual intercourse 
and hearing of Nexplanon®.  
Hormonal methods were the next most frequently used contraception reported by 
our participants. This is consistent with the overwhelming amount of evidence showing 
that OCPs continue to be the most prevalent contraceptive methods used by adolescent 
and young adult women (Finer & Philbin, 2013). Although this was consistently seen 
throughout our total sub-group population, the use of hormonal contraceptive methods 
was seen more among the participants who were familiar with Nexplanon® (30.4%) 
compared to those unfamiliar with Nexplanon® (26.2%).  
Practicing withdrawal and not using a contraceptive method at all closely 
followed the use of hormonal methods among participants unfamiliar with Nexplanon® 
(21.5%) and was much less than the 53% of 14-19 year-old females who reported the 
same contraceptive decisions when presenting to a PED (Miller, Randell, Barral, 
Sherman, & Miller, 2016). In contrast, hormonal use among participants who were 
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familiar with Nexplanon® was followed by LARC use (20.6%) instead of withdrawal 
and no contraceptive method (12.7%). It was promising to see condoms used least 
throughout our sub-group analysis population (4.2%)—more than half of the current 
condom use reported by women nationally (9.2%) (Daniels et al., 2014). The patterns of 
use with less effective contraceptive methods seen among our sub-group analysis 
population might suggest that young women who are aware of Nexplanon® are also 
generally more aware of and prefer using alternative contraceptive methods as opposed to 
practicing withdrawal or not using a contraceptive method altogether.  
LARC use among our total sub-group analysis population (15.8%) was three 
times greater than the current LARC use reported by 15-24 year-old females from the 
2011-2013 NSFG cycle (5.0%) (Branum & Jones, 2015). In our study, LARC use among 
participants familiar with Nexplanon® (20.6%) was more than three times greater than 
LARC use among participants unfamiliar with Nexplanon® (6.5%). This data contributes 
to the large body of evidence supporting the vital role that LARC awareness has on 
increasing the uptake of LARC methods, especially Nexplanon® (Kavanaugh et al., 
2013). 
Current Nexplanon®  Users 
6% (22/366) of our sub-group analysis population identified the contraceptive 
implant as their current method of contraception at the time they completed the survey. 
This was an encouraging six times greater than the 0.8% using the contraceptive implant 
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among women of all reproductive ages from the 2011– 2013 NSFG survey cycle 
(Branum & Jones, 2015) and twice as much as the 3% of young women aged 14-19 years 
presenting to a PED (Miller et al., 2016). Our results demonstrate an upward trend in 
implant uptake among US women of all reproductive ages (15-44), but also, suggests 
increased implant use among women disproportionately affected by unintended 
pregnancy—14-20 year-old adolescent and young adult women (Chernick et al., 2012).   
Willingness to Initiate or Switch to Nexplanon®  during a PED Visit 
 Only 9.6% of the participants in our overall sub-group analysis population 
reported that they would initiate or switch to the implant if it was offered to them in the 
PED. However, the proportion of participants who had heard of Nexplanon® who were 
willing to initiate or switch to the implant if it was offered in the PED was double the 
proportion of willing participants who had not heard of Nexplanon®. These findings 
suggest that the proportion of young women willing to initiate or switch to the implant if 
offered in the PED has the potential to increase if there were more efforts made to 
increase the awareness of Nexplanon®. These findings are consistent with those of a 
similar study that reported 28.8% of their study population expressing an interest in 
initiating the implant in the PED setting (Miller et al., 2016). 
Receptivity to Learning about Birth Control in the PED 
 The majority (67.6%) of our sub-group analysis total population expressed an 
interest in learning about contraceptive methods in the PED. These findings are 
consistent with the attitudes of many adolescent and young adult females concerning 
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contraceptive education and information (Bachorik et al., 2015). This openness to 
learning more about contraceptive methods in the PED will hopefully translate into an 
increased uptake of one of the most effective methods of contraception, especially the 
subdermal implant, and its continued use and satisfaction (Obijuru, Bumpus, Auinger, & 
Baldwin, 2016). 
Limitations 
There are several limitations to our subgroup analysis study. Since our study 
analyzed a sub-group of a population selected by a larger cross-sectional study, our 
results cannot be generalized to describe the overall adolescent and young adult women 
populations. The associations identified may only be used to describe the 16-21 year-old 
adolescent and young adult females who responded to the survey questions of interest to 
our subgroup analysis. Again, due to the cross-sectional nature of our sub-group analysis, 
any associations identified through our survey should not be construed as causal 
relationships. Further studies are required in order to establish any temporal relationships 
between variables.  
Another factor that should be considered is that the females that participated in 
our subgroup analysis were part of a larger population that represented a convenience 
sample. Thus, our subgroup analysis may exclude young women who are knowledgeable 
about Nexplanon®, but chose not to participate in the study. 
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Due to the low statistical power associated with small sample sizes, characteristics 
found to be statistically significant and therefore strongly associated with our sub-group 
analysis population might be overestimations and not reflect true effects.  
As a result of the anonymous completion of our surveys, all collected data was self-
reported and, therefore, subject to recall bias. Also, since respondents were left alone in a 
PED exam room to complete the survey, it is possible that respondents interpreted survey 
questions differently from what was originally intended when survey questions were 
written.   
Another limitation of our subgroup analysis refers to the difference in being 
knowledgeable and familiar with Nexplanon®. Since our survey did not ask any 
qualitative questions testing the accuracy of the participants’ knowledge about 
Nexplanon®, the degree to which these young women are familiar with Nexplanon® is 
not determinable from our analysis.   
Lastly, this subgroup analysis was part of a one-time survey that has not followed 
up on any of the participants. Therefore, any clarifications or comments regarding the 
questions answered by the participants are not applicable to the date we collected.  
Clinical Implications and Contributions to Existing Literature 
Despite the limitations associated with our sub-group analysis, there any many clinical 
implications that are supported by our findings.  An overwhelming amount of the 
literature has proven that accessibility and education are among the largest barriers to the 
increase of LARC uptake among adolescent and young adult women (Murphy et al., 
2016). In response to this evidence, there have been a number of clinic-based 
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interventions, in addition to CHOICE, that have provided further support of the 
importance of convenient access and proper contraceptive knowledge in the contraceptive 
method decision-making process for young women (Harper et al., 2015). In a study that 
examined contraceptive method use among females aged 15-19 years seeking 
contraceptive services at Title X funded sites from 2005 to 2013, Romero et al. found a 
fifteen-fold increase in the uptake of the most effective methods of reversible 
contraception in the setting of increased health care provider awareness of LARC clinical 
guidelines and device training as well as patient-centered contraceptive counseling. One 
out of every fourteen 15-19 year-old females chose one of the most effective LARC 
methods over other moderately and least effective methods (Romero et al., 2015). In light 
of the encouraging increase in LARC uptake displayed in a wide variety of health care 
facilities, ED-based interventions should also be considered.   
In an ED-based study conducted by Miller et al., only 27% of the adolescents and 
young adults presenting to a PED reported having any previous counseling on 
contraceptive methods. This is a concerning statistic that can be addressed by 
implementing comprehensive contraceptive counseling in the PED environment. This 
implementation is supported by additional evidence from previous ED-based studies and 
interventions that suggest how instrumental the PED can be in providing comprehensive 
contraceptive services among adolescent and young adult women in the US (Fine & 
Mollen, 2010).  
In addition to providing complete and accurate information on contraceptive 
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method options, PEDs should be included in the list of clinical settings that are optimized 
to implement LARC provision—especially in the case of Nexplanon®. The potential of 
increased LARC uptake through the PED is supported by a recent study that found the 
increase in implant uptake to surpass the increase in IUD uptake among young women 
between 2005 and 2013 (Romero et al., 2015). These findings suggest that young women 
are choosing the most effective contraceptive methods in clinical settings where LARC 
devices are conveniently offered.  
Although there have been many previous studies that have focused on adolescent 
awareness and knowledge of LARCs, this sub-group analysis contributes to a small pool 
of existing studies based in the PED (Miller et al., 2014). Overall, our study findings are 
supportive of and consistent with the provision and education of Nexplanon® in the 
PED. This would be a crucial opportunity to provide comprehensive contraceptive 
counseling and convenient access to the most effective method of contraception among a 
population that disproportionately affected by unintended pregnancy. This can be made 
possible by enabling PED health care providers with the proper access to and training in 
Nexplanon® which showed twice as much LARC uptake among women at clinics 
randomized to these types of intervention (Harper et al., 2015). By adapting these patient-
centered practices and techniques, the PED setting can contribute to the notable reduction 
in teen pregnancy seen in a variety of similar clinic-based interventions (McNicholas, 
Madden, Secura, & Peipert, 2014). The PED atmosphere has enormous potential to serve 
young women as an additional venue for contraception education and access. 
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APPENDIX 
A. Study Questionnaire  
Section A: Background Information 
1. How old are you? __________________ years old 
 
2. Are you Hispanic, Latina or of Spanish origin? 
  Yes 
  No 
 
3. What is your race/ethnicity? (Check all that apply.)         
  Black or African American    Asian 
  White or Caucasian     Other: 
________________________________ 
 
4. What is the highest level of education you have completed?   
  Junior high school                     Some college but no degree 
  Some high school    2-yr college (Associates) degree  
  High school graduate or GED   Other: 
________________________________ 
  
5. What is the highest level of education completed by your parent(s)?   
  Less than high school    2-yr college (Associates) degree  
  High school graduate or GED   4-year college graduate (BA, BS) 
  Some college but no degree     Graduate or professional school 
  Don’t know 
 
6. What is the highest level of education you plan to complete?   
  High school graduate or GED   4-year college graduate (BA, BS) 
  2-year college degree (Associates degree)  Graduate or professional school 
  Don’t know 
 
7. Do you have a primary care physician (regular doctor)? 
  Yes 
  No (If no, skip to question 9B) 
 
8. When is the last time you saw your primary care physician (regular doctor)? 
   Within the last year 
   Between 1- 2 years ago 
   Over 2 years ago 
 
9. Have you ever talked about birth control options with your primary care physician (regular 
doctor) and/or a parent? 
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 9A) Your doctor:  Yes   9B) A parent:  Yes 
                                 No    No 
 
10. What brought you to the ER today? (Examples: sore throat, fever, abdominal pain): 
_________________________________________________________________________ 
 
Section B. Sexual Health History and Birth Control 
11. If you were being seen in the emergency room for a problem, even if that problem was not 
related to your sexual health, would you be open to learning about birth control? 
   Yes 
   No  
 
12.  Have you ever been sexually active with boys? (By this, we mean vaginal sex) 
   Yes 
   No  (If no, skip to question 15) 
 
13. What type of birth control are you using now?        Birth control in the past? 
 (Check all that apply.)    (Check all that apply.) 
   Abstinence             Abstinence 
   Birth control pills, ring, or patch            Birth control pills, ring, or patch 
   Injectable (Depo- Provera shot)             Injectable (Depo- Provera shot) 
   IUD (Mirena, Skyla, Copper Paragard)           IUD (Mirena, Skyla, Copper Paragard) 
   Implantable (Implanon/Nexplanon            Implantable (Implanon/Nexplanon) 
   Withdrawal method (“pulling out”)            Withdrawal method (“pulling out”) 
   Condoms              Condoms 
   None                          None 
   Other: _____________________                    Other: _____________________ 
 
14 A. Are you happy w/ your current method of birth control?  
   Yes (If yes, skip to Question 15) 
   No  (If no, continue to Question 14B) 
 
14 B. If no, why not? (Examples: requires a doctor visit, irregular bleeding, weight gain, can’t 
remember to take/use.)  
 
 
 
 
 
15. If you could start or change to any type of birth control of your choice here in the emergency 
room, how likely would you be to start it today? 
  
Unlikely     Neutral                          Likely 
      1                                2                                3                                4                                 5
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16. Which birth control method(s) would you be willing to start or change to if it was offered to 
you here in the emergency room today. (Check all that apply.) 
   Birth control pills, ring, or patch    
   Injectable (Depo- Provera shot)     
   IUD (Intra uterine device: Mirena, Skyla, Copper Paragard)     
   Implantable (Implanon/Nexplanon)       
   I’m happy with my birth control method and would not change to a different kind  
   None 
   Other: ____________________________  
 
17. Have you heard of the implantable birth control device Nexplanon that goes under the skin in   
the upper arm (Previously known as Implanon), which is the size of a matchstick and lasts for 3 
years)? 
   Yes 
   No (If no, skip to Question 19) 
 
18. How did you hear about Nexplanon?  (Check all that apply.) 
   Friends, family    Media (internet, magazines) 
   Medical professional (School nurse, 
        Primary Care Doctor, Nurse, clinic) 
   Other  _______________________ 
 
19. Have you ever been diagnosed with a STD (sexually transmitted disease)? (Examples: 
Gonorrhea, Chlamydia, Herpes, Trichomoniasis) 
  Yes                 No 
 
20. How many times have you been pregnant?  ______________ (List # of times pregnant) 
 
Thank you for taking the time to complete this survey.
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B. Participant Informational Handout 
 
Birth Control and Sexual Health Survey 
This is a research study about birth control use and sexual health among 16 to 21 year old 
females. It is an anonymous questionnaire, meaning, no information that could identify 
you will be associated with the questionnaire that you will be asked to fill out. There are 
20 questions that should take about 5-10 minutes to complete. The information you give 
will be used to help us better understand the birth control needs of adolescents and young 
women who come to our emergency room. The only risk in participating is the potential 
for loss of confidentiality.  
No one will know if and how you answered the questions because we are not collecting 
any personal information; this is an anonymous survey. DO NOT write your name on this 
survey. Answer the questions based on how you really feel. There are no right or wrong 
answers to the questions. By completing the survey, you are indicating your willingness 
to participate in this study.  
If you are uncomfortable answering a question, just leave it blank.  
Whether or not you answer the questions will not affect your treatment in the emergency 
room. Completing the survey is voluntary. The questions that ask about your background 
will be used only to generally describe the people who are taking part in this study. Once 
the study is completely done, we will make a report summarizing what we learned from 
the answers provided in the questionnaires. All surveys collected will be kept in a secure, 
locked location and any data will be stored in a secure database.  
When you are finished, please place your completed survey in the unmarked envelope 
and place it in the box marked “Survey.”  
You may contact Atsuko Koyama, MD at 617-414-6334, if you have any questions about 
the study.  
The Institutional Review Board at the Boston University Medical Campus oversees all 
research studies at Boston Medical Center. Please contact them at 617-638- 7207 or 
medirb@bu.edu if you have any questions about being a research subject in this study.  
Thank you for your time.  
       BUMC/BMC Institutional Review Board 
       IRB NUMBER: H-32850 
       IRB APPROVAL DATE: 04/16/2014 
       IRB EXPIRATION DATE: 04/15/2015
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C. Guardian Informational Handout 
 
Birth Control and Sexual Health 
 
What is the research study that my daughter has volunteered for? 
Your daughter has volunteered to participate in a research study that lasts just for 
the period of time she is visiting the Pediatric Emergency Department at Boston 
Medical Center. State of Massachusetts guidelines indicate that minors can 
provide their own consent or permission, without parental input, for health-care 
related decisions regarding matters of reproductive health. Along these lines, your 
daughter was asked if she would be willing to fill out a research questionnaire 
about questions regarding reproductive health choices.  The survey is strictly 
anonymous. No identifying information is provided on the survey, meaning that it 
will be impossible for anyone to know who the answers belong to. 
 
What is the study about? 
This is a research study focusing on adolescents’ and young women’s thoughts 
about birth control and their sexual health. The study is being conducted at Boston 
Medical Center. The purpose of this study is to find out more about adolescents’ 
and young women’s contraceptive needs, including whether or not young women 
may desire contraception from the emergency department. The hope is that your 
daughter’s participation will ultimately help improve medical care.  About 300 
women between the ages of 16 to 21 are being asked to take part in this study.    
 
What will my daughter be doing? 
We are asking young women to complete an anonymous questionnaire with 20 
questions.     
 
What happens to the information my daughter provides? 
We will not record any identifying information. The completed anonymous 
questionnaires will be stored in a safe and secure location in a research study 
office at Boston Medical Center. Information from this study may be reviewed 
and photocopied by state and federal regulatory agencies such as U.S. 
Government’s Office of Human Research Protection and the Institutional Review 
Board of the Boston University Medical Campus, which oversees the conduct of 
all human subject research at Boston Medical Center. 
 
Who can I contact for more information? 
The Institutional Review Board at the Boston University Medical Campus 
oversees all research studies at Boston Medical Center. Please contact them at 
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617-638-7207 or medirb@bu.edu if you have any questions about your daughter 
being a research subject in this study. 	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	44 
REFERENCES 
Abraham, M., Zhao, Q., & Peipert, J. F. (2015). Young Age, Nulliparity, and 
Continuation of Long-Acting Reversible Contraceptive Methods. 
Obstetrics and Gynecology, 126(4), 823–829. 
http://doi.org/10.1097/AOG.0000000000001036 
American Teens’ Sexual and Reproductive Health. (2016, June 1). Retrieved July 
1, 2016, from https://www.guttmacher.org/fact-sheet/american-teens-
sexual-and-reproductive-health 
Bachorik, A., Friedman, J., Fox, A., Nucci, A. T., Horowitz, C. R., & Diaz, A. 
(2015). Adolescent and Young Adult Women’s Knowledge of and 
Attitudes Toward Etonogestrel Implants. Journal of Pediatric and 
Adolescent Gynecology, 28(4), 229–233. 
http://doi.org/10.1016/j.jpag.2014.08.002 
Bader, V., Kelly, P. J., Cheng, A.-L., & Witt, J. (2014). The role of previous 
contraception education and moral judgment in contraceptive use. Journal 
of Midwifery & Women’s Health, 59(4), 447–451. 
http://doi.org/10.1111/jmwh.12149 
Biggs, M. A., Arons, A., Turner, R., & Brindis, C. D. (2013). Same-day LARC 
insertion attitudes and practices. Contraception, 88(5), 629–635. 
http://doi.org/10.1016/j.contraception.2013.05.012 
	45 
Birgisson, N. E., Zhao, Q., Secura, G. M., Madden, T., & Peipert, J. F. (2015). 
Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in 
Review. Journal of Women’s Health (2002), 24(5), 349–353. 
http://doi.org/10.1089/jwh.2015.5191 
Branum, A. M., & Jones, J. (2015). Trends in long-acting reversible contraception 
use among U.S. women aged 15-44. NCHS Data Brief, (188), 1–8. 
Carter, M. W., Bergdall, A. R., Henry-Moss, D., Hatfield-Timajchy, K., & Hock-
Long, L. (2012). A qualitative study of contraceptive understanding 
among young adults. Contraception, 86(5), 543–550. 
http://doi.org/10.1016/j.contraception.2012.02.017 
Chernick, L., Kharbanda, E. O., Santelli, J., & Dayan, P. (2012). Identifying 
Adolescent Females at High Risk of Pregnancy in a Pediatric Emergency 
Department. Journal of Adolescent Health, 51(2), 171–178. 
http://doi.org/10.1016/j.jadohealth.2011.11.023 
Craig, A. D., Dehlendorf, C., Borrero, S., Harper, C. C., & Rocca, C. H. (2014). 
Exploring young adults’ contraceptive knowledge and attitudes: disparities 
by race/ethnicity and age. Women’s Health Issues: Official Publication of 
the Jacobs Institute of Women’s Health, 24(3), e281-289. 
http://doi.org/10.1016/j.whi.2014.02.003 
	46 
Daniels, K., Daugherty, J., & Jones, J. (2014). Current contraceptive status among 
women aged 15-44: United States, 2011-2013. NCHS Data Brief, (173), 
1–8. 
Denno, D. M., Hoopes, A. J., & Chandra-Mouli, V. (2015). Effective strategies to 
provide adolescent sexual and reproductive health services and to increase 
demand and community support. The Journal of Adolescent Health: 
Official Publication of the Society for Adolescent Medicine, 56(1 Suppl), 
S22-41. http://doi.org/10.1016/j.jadohealth.2014.09.012 
Fine, L. C., & Mollen, C. J. (2010). A Pilot Study to Assess Candidacy for 
Emergency Contraception and Interest in Sexual Health Education in a 
Pediatric Emergency Department Population: Pediatric Emergency Care, 
26(6), 413–416. http://doi.org/10.1097/PEC.0b013e3181e0578f 
Finer, L. B. (2010). Unintended Pregnancy Among U.S. Adolescents: Accounting 
for Sexual Activity. Journal of Adolescent Health, 47(3), 312–314. 
http://doi.org/10.1016/j.jadohealth.2010.02.002 
Finer, L. B., & Philbin, J. M. (2013). Sexual initiation, contraceptive use, and 
pregnancy among young adolescents. Pediatrics, 131(5), 886–891. 
http://doi.org/10.1542/peds.2012-3495 
Finer, L. B., & Zolna, M. R. (2016). Declines in Unintended Pregnancy in the 
United States, 2008–2011. New England Journal of Medicine, 374(9), 
843–852. http://doi.org/10.1056/NEJMsa1506575 
	47 
Fontenot, H. B., & Fantasia, H. C. (2015). Long-Acting Reversible Contraception 
for Adolescents. Nursing for Women’s Health, 19(3), 253–259. 
http://doi.org/10.1111/1751-486X.12207 
Foster, D. G., Barar, R., Gould, H., Gomez, I., Nguyen, D., & Biggs, M. A. 
(2015). Projections and opinions from 100 experts in long-acting 
reversible contraception. Contraception, 92(6), 543–552. 
http://doi.org/10.1016/j.contraception.2015.10.003 
Frost, J. J., & Darroch, J. E. (2008). Factors associated with contraceptive choice 
and inconsistent method use, United States, 2004. Perspectives on Sexual 
and Reproductive Health, 40(2), 94–104. http://doi.org/10.1363/4009408 
Frost, J. J., Lindberg, L. D., & Finer, L. B. (2012). Young adults’ contraceptive 
knowledge, norms and attitudes: associations with risk of unintended 
pregnancy. Perspectives on Sexual and Reproductive Health, 44(2), 107–
116. http://doi.org/10.1363/4410712 
Harper, C. C., Rocca, C. H., Thompson, K. M., Morfesis, J., Goodman, S., 
Darney, P. D., … Speidel, J. J. (2015). Reductions in pregnancy rates in 
the USA with long-acting reversible contraception: a cluster randomised 
trial. Lancet (London, England), 386(9993), 562–568. 
http://doi.org/10.1016/S0140-6736(14)62460-0 
Hathaway, M., Torres, L., Vollett-Krech, J., & Wohltjen, H. (2014). Increasing 
LARC utilization: any woman, any place, any time. Clinical Obstetrics 
	48 
and Gynecology, 57(4), 718–730. 
http://doi.org/10.1097/GRF.0000000000000071 
Hoopes, A. J., Gilmore, K., Cady, J., Akers, A. Y., & Ahrens, K. R. (2015). A 
Qualitative Study of Factors That Influence Contraceptive Choice among 
Adolescent School-Based Health Center Patients. Journal of Pediatric and 
Adolescent Gynecology. http://doi.org/10.1016/j.jpag.2015.09.011 
Kavanaugh, M. L., Jerman, J., Ethier, K., & Moskosky, S. (2013). Meeting the 
contraceptive needs of teens and young adults: youth-friendly and long-
acting reversible contraceptive services in U.S. family planning facilities. 
The Journal of Adolescent Health: Official Publication of the Society for 
Adolescent Medicine, 52(3), 284–292. 
http://doi.org/10.1016/j.jadohealth.2012.10.276 
Khurana, A., & Bleakley, A. (2015). Young adults’ sources of contraceptive 
information: variations based on demographic characteristics and sexual 
risk behaviors. Contraception, 91(2), 157–163. 
http://doi.org/10.1016/j.contraception.2014.09.012 
Madden, T., Mullersman, J. L., Omvig, K. J., Secura, G. M., & Peipert, J. F. 
(2013). Structured contraceptive counseling provided by the Contraceptive 
CHOICE Project. Contraception, 88(2), 243–249. 
http://doi.org/10.1016/j.contraception.2012.07.015 
	49 
Martinez, G., Copen, C. E., & Abma, J. C. (2011). Teenagers in the United States: 
sexual activity, contraceptive use, and childbearing, 2006-2010 national 
survey of family growth. Vital and Health Statistics. Series 23, Data from 
the National Survey of Family Growth, (31), 1–35. 
McNicholas, C., Madden, T., Secura, G., & Peipert, J. F. (2014). The 
contraceptive CHOICE project round up: what we did and what we 
learned. Clinical Obstetrics and Gynecology, 57(4), 635–643. 
http://doi.org/10.1097/GRF.0000000000000070 
Mestad, R., Secura, G., Allsworth, J. E., Madden, T., Zhao, Q., & Peipert, J. F. 
(2011). Acceptance of long-acting reversible contraceptive methods by 
adolescent participants in the Contraceptive CHOICE Project. 
Contraception, 84(5), 493–498. 
http://doi.org/10.1016/j.contraception.2011.03.001 
Miller, M. K., Mollen, C. J., O’Malley, D., Owens, R. L., Maliszewski, G. A., 
Goggin, K., & Kelly, P. (2014). Providing adolescent sexual health care in 
the pediatric emergency department: views of health care providers. 
Pediatric Emergency Care, 30(2), 84–90. 
http://doi.org/10.1097/PEC.0000000000000076 
Miller, M. K., Pickett, M., Leisner, K., Sherman, A. K., & Humiston, S. G. 
(2013). Sexual Health Behaviors, Preferences for Care, and Use of Health 
Services Among Adolescents in Pediatric Emergency Departments: 
	50 
Pediatric Emergency Care, 29(8), 907–911. 
http://doi.org/10.1097/PEC.0b013e31829ec244 
Miller, M. K., Randell, K. A., Barral, R., Sherman, A. K., & Miller, E. (2016). 
Factors Associated With Interest in Same-Day Contraception Initiation 
Among Females in the Pediatric Emergency Department. The Journal of 
Adolescent Health: Official Publication of the Society for Adolescent 
Medicine, 58(2), 154–159. http://doi.org/10.1016/j.jadohealth.2015.10.016 
Murphy, M. K., Stoffel, C., Nolan, M., & Haider, S. (2016). Interdependent 
barriers to providing adolescents with long-acting reversible contraception 
(LARC): Qualitative insights from providers. Journal of Pediatric and 
Adolescent Gynecology. http://doi.org/10.1016/j.jpag.2016.01.125 
Obijuru, L., Bumpus, S., Auinger, P., & Baldwin, C. D. (2016). Etonogestrel 
Implants in Adolescents: Experience, Satisfaction, and Continuation. The 
Journal of Adolescent Health: Official Publication of the Society for 
Adolescent Medicine, 58(3), 284–289. 
http://doi.org/10.1016/j.jadohealth.2015.10.254 
OʼNeil-Callahan, M., Peipert, J. F., Zhao, Q., Madden, T., & Secura, G. (2013). 
Twenty-Four–Month Continuation of Reversible Contraception: 
Obstetrics & Gynecology, 122(5), 1083–1091. 
http://doi.org/10.1097/AOG.0b013e3182a91f45 
	51 
Parks, C., & Peipert, J. F. (n.d.). Eliminating health disparities in unintended 
pregnancy with long-acting reversible contraception (LARC). American 
Journal of Obstetrics and Gynecology. 
http://doi.org/10.1016/j.ajog.2016.02.017 
Potter, J., Koyama, A., & Coles, M. S. (2015). Addressing the challenges of 
clinician training for long-acting reversible contraception. JAMA 
Pediatrics, 169(2), 103–104. 
http://doi.org/10.1001/jamapediatrics.2014.2812 
Raidoo, S., & Kaneshiro, B. (2015). Providing Contraception to Adolescents. 
Obstetrics and Gynecology Clinics of North America, 42(4), 631–645. 
http://doi.org/10.1016/j.ogc.2015.08.004 
Romero, L., Pazol, K., Warner, L., Gavin, L., Moskosky, S., Besera, G., … 
Centers for Disease Control and Prevention (CDC). (2015). Vital signs: 
trends in use of long-acting reversible contraception among teens aged 15-
19 years seeking contraceptive services—United States, 2005-2013. 
MMWR. Morbidity and Mortality Weekly Report, 64(13), 363–369. 
Rosenstock, J. R., Peipert, J. F., Madden, T., Zhao, Q., & Secura, G. M. (2012). 
Continuation of Reversible Contraception in Teenagers and Young 
Women: Obstetrics & Gynecology, 120(6), 1298–1305. 
http://doi.org/10.1097/AOG.0b013e31827499bd 
	52 
Secura, G. M., Adams, T., Buckel, C. M., Zhao, Q., & Peipert, J. F. (2014). 
Change in Sexual Behavior With Provision of No-Cost Contraception: 
Obstetrics & Gynecology, 123(4), 771–776. 
http://doi.org/10.1097/AOG.0000000000000184 
Secura, G. M., Allsworth, J. E., Madden, T., Mullersman, J. L., & Peipert, J. F. 
(2010). The Contraceptive CHOICE Project: reducing barriers to long-
acting reversible contraception. American Journal of Obstetrics and 
Gynecology, 203(2), 115.e1-115.e7. 
http://doi.org/10.1016/j.ajog.2010.04.017 
Secura, G. M., Madden, T., McNicholas, C., Mullersman, J., Buckel, C. M., Zhao, 
Q., & Peipert, J. F. (2014). Provision of no-cost, long-acting contraception 
and teenage pregnancy. The New England Journal of Medicine, 371(14), 
1316–1323. http://doi.org/10.1056/NEJMoa1400506 
Sedgh, G., Finer, L. B., Bankole, A., Eilers, M. A., & Singh, S. (2015). 
Adolescent pregnancy, birth, and abortion rates across countries: levels 
and recent trends. The Journal of Adolescent Health: Official Publication 
of the Society for Adolescent Medicine, 56(2), 223–230. 
http://doi.org/10.1016/j.jadohealth.2014.09.007 
Society for Adolescent Health and Medicine, Burke, P. J., Coles, M. S., Di 
Meglio, G., Gibson, E. J., Handschin, S. M., … Urbach, K. (2014). Sexual 
and reproductive health care: a position paper of the Society for 
	53 
Adolescent Health and Medicine. The Journal of Adolescent Health: 
Official Publication of the Society for Adolescent Medicine, 54(4), 491–
496. http://doi.org/10.1016/j.jadohealth.2014.01.010 
Sonfield, A., Kost, K., Gold, R. B., & Finer, L. B. (2011). The Public Costs of 
Births Resulting from Unintended Pregnancies: National and State-Level 
Estimates. Perspectives on Sexual and Reproductive Health, 43(2), 94–
102. http://doi.org/10.1363/4309411 
Spies, E. L., Askelson, N. M., Gelman, E., & Losch, M. (2010). Young women’s 
knowledge, attitudes, and behaviors related to long-acting reversible 
contraceptives. Women’s Health Issues: Official Publication of the Jacobs 
Institute of Women’s Health, 20(6), 394–399. 
http://doi.org/10.1016/j.whi.2010.07.005 
Winner, B., Peipert, J. F., Zhao, Q., Buckel, C., Madden, T., Allsworth, J. E., & 
Secura, G. M. (2012). Effectiveness of long-acting reversible 
contraception. The New England Journal of Medicine, 366(21), 1998–
2007. http://doi.org/10.1056/NEJMoa1110855 
 							
	54 
VITA 
KAVITA H. JARIWALA 
 
Address:  2121 Brook Highland Ridge 
   Birmingham, AL 35242 
   205-542-6485 
 
Email:   kavita.h.jariwala@gmail.com 
 
Year of Birth: 1989 
 
Education:  Auburn University 
   Bachelor of Arts in Chemistry, December 2011 
 
   Boston University School of Medicine, Boston, MA 
   Candidate for Master of Arts of Medical Sciences, May 
2016 
   Coursework: Biochemistry and Cell Biology, 
Pharmacology,  
   Pathology, Human Physiology, Cellular Organization of 
Tissues 
 
Research Experience: 
 
01/2010- 05/2010 Undergraduate Research Program  
• Using Acyclic 1, 3- Dienes as Models for the 
Photoisomerization of Retinal  
 
05/2010- 12/2010 Cellular and Molecular Biology Fellowship  
• Continuation of Research on: Using Acyclic 1, 3- 
Dienes as Models for the Photoisomerization of 
Retinal 
 
 
Medically Relevant Experiences: 
 
05/2007- 12/2013 Independent Shadowing 
• Primary Care 
• OB-GYN 
• Cardiology 
	55 
• General Surgery 
• Cardiac Vascular and Thoracic Surgery 
• Neurosurgery 
• Orthopedics 
• Emergency Medicine 
 
10/2010- 05/2011 Medical D Volunteer Auburn, AL 
• Magnolia Place Senior Citizen Service Organization 
 
06/2011- 08/2011 Georgetown Summer Medical Institute 
• 6 week Intensive Gross Anatomy Course 
• Cadaver Lab Experience 
 
01/2012- 03/2013 Emergency Department Medical Scribe 
• Emergency Medical Associates: Reston Hospital 
Center Reston, VA 
• Scribe America: Virginia Hospital Center 
Arlington, VA 
03/2016- 08/2016 Emergency Department Medical Scribe 
• Scribe America: Massachusetts General Hospital 
Boston, MA 
• Scribe America: Brigham and Women’s Hospital 
Boston, MA 
 
Awards: 
 
09/2009-12/2012 Dean’s List 
 
05/2010-12/2010 Cellular and Molecular Biology Fellowship 
 
10/2012-12/2012 Phi Kappa Phi Honor Society 
 
Graduated 12/12/11 Summa Cum Laude 
 
Volunteer Work: 
 
08/2010- 05/2011 Project Uplift 
• Agency with goal to help children develop happy 
and constructive lives through positive role models 
 
	56 
08/2010-12/2011 Auburn Athletic Department Tutor 
• Tutored student-athletes in organic chemistry and 
biochemistry                                                                           	
